The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis

British Journal of Dermatology

Volumn 165, Issue 2, 2011, Pages 329-334

  Danby, S G ^a   Al Enezi, T ^a   Sultan, A ^a   Chittock, J ^a   Kennedy, K ^a   Cork, M J ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS CREAM BP; EMOLLIENT AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM; HUMAN; HUMAN TISSUE; MALE; PERMEABILITY BARRIER; PRIORITY JOURNAL; SKIN WATER LOSS; STRATUM CORNEUM;

ADULT; COHORT STUDIES; DERMATITIS, ATOPIC; DISEASE SUSCEPTIBILITY; DRUG ERUPTIONS; EMOLLIENTS; EPIDERMIS; FEMALE; FOREARM; HUMANS; MALE; SKIN; SODIUM DODECYL SULFATE; WATER LOSS, INSENSIBLE;

EID: 79960646458     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10395.x     Document Type: Article

References (31)

1. Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009; 129: 1892-908.
2. Batchelor JM, Grindlay DJ, Williams HC,. What's new in atopic eczema? An analysis of systematic reviews published in 2008 and 2009. Clin Exp Dermatol 2010; 35: 823-7.
3. Elias PM, Steinhoff M,. 'Outside-to-inside' (and now back to 'outside') pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008; 128: 1067-70. (Pubitemid 351543225)
4. Danby S, Cork MJ,. A new understanding of atopic dermatitis: the role of epidermal barrier dysfunction and subclinical inflammation. J Clin Dermatol 2010; 1: 33-46.
5. Lewis-Jones S, Cork MJ, Clark C, et al. Atopic Eczema in Children-Guideline Consultation: A Systematic Review of the Treatments for Atopic Eczema and Guideline for its Management. London: National Institute for Clinical Excellence (NICE), 2007.
6. Cork MJ, Danby S,. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nurs 2009; 18: 872, 874, 876-7.
7. Cork MJ, Britton J, Butler L, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003; 149: 582-9. (Pubitemid 37281592)
8. Bissonnette R, Maari C, Provost N, et al. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis. J Cosmet Dermatol 2010; 9: 16-21.
9. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47: 198-208.
10. Msika P, De Belilovsky C, Piccardi N, et al. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol 2008; 25: 606-12.
11. Wiren K, Nohlgard C, Nyberg F, et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009; 23: 1267-72.
12. British National Formulary 61. London: BMJ Group and Pharmaceutical Press, 2011.
13. Cork MJ, Timmins J, Holden C, et al. An audit of adverse drug reactions to aqueous cream in children with atopic eczema. Pharm J 2003; 271: 746-7.
14. NHS Information Centre Prescribing Support Unit. Prescription Cost Analysis England 2009. London: NHS Information Centre for Health and Social Care, 2010. Available at: (last accessed 29 May 2011).
15. Kao JS, Fluhr JW, Man MQ, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003; 120: 456-64. (Pubitemid 36298433)
16. Williams HC, Burney PG, Pembroke AC, Hay RJ,. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol 1996; 135: 12-17. (Pubitemid 26225107)
17. Imhof RE, De Jesus ME, Xiao P, et al. Closed-chamber transepidermal water loss measurement: microclimate, calibration and performance. Int J Cosmet Sci 2009; 31: 97-118.
18. Pinnagoda J, Tupker RA, Agner T, et al. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22: 164-78. (Pubitemid 20106155)
19. Tsang M, Guy RH,. Effect of aqueous cream BP on human stratum corneum in vivo. Br J Dermatol 2010; 163: 954-8.
20. Fluhr JW, Feingold KR, Elias PM,. Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models. Exp Dermatol 2006; 15: 483-92. (Pubitemid 43834482)
21. Machado M, Salgado TM, Hadgraft J, et al. The relationship between transepidermal water loss and skin permeability. Int J Pharm 2010; 384: 73-7.
22. Gupta J, Grube E, Ericksen MB, et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol 2008; 121: 725-30.e2.
23. Voegeli R, Rawlings AV, Breternitz M, et al. Increased stratum corneum serine protease activity in acute eczematous atopic skin. Br J Dermatol 2009; 161: 70-7.
24. Lee Y, Hwang K,. Skin thickness of Korean adults. Surg Radiol Anat 2002; 24: 183-9. (Pubitemid 35189505)
25. White MI, Jenkinson DM, Lloyd DH,. The effect of washing on the thickness of the stratum corneum in normal and atopic individuals. Br J Dermatol 1987; 116: 525-30. (Pubitemid 17036879)
26. Boralevi F, Hubiche T, Léauté-Labrèze C, et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants-determining the role of epidermal barrier impairment. Allergy 2008; 63: 205-10.
27. Gloor M, Hauth A, Gehring W,. O/W emulsions compromise the stratum corneum barrier and improve drug penetration. Pharmazie 2003; 58: 709-15. (Pubitemid 37328400)
28. Tupker RA, Willis C, Berardesca E, et al. Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1997; 37: 53-69. (Pubitemid 27390280)
29. Gloor M,. How do dermatological vehicles influence the horny layer? Skin Pharmacol Physiol 2004; 17: 267-73. (Pubitemid 39482580)
30. Fluhr J, Bankova LG,. Skin surface pH: mechanism, measurement, importance. In: Handbook of Non-Invasive Methods and the Skin (, Serup J, Jemec GB, Grove GL, eds). Boca Raton: CRC Press, 2006; 411-20.
31. Ananthapadmanabhan KP, Moore DJ, Subramanyan K, et al. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther 2004; 17 (Suppl. 1): 16-25.